MoneyWorks4Me

Parabolic Drugs informs about standalone financial results

18 Aug 2016 Evaluate

Parabolic Drugs has informed about Standalone Financial Results and Limited Review for the period ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..